These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 11956072)

  • 1. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
    Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
    Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
    Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
    Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
    Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
    Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score.
    Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B
    Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
    Stewart J; Fleshner N; Cole H; Sweet J
    J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
    Rubin MA; Bismar TA; Andrén O; Mucci L; Kim R; Shen R; Ghosh D; Wei JT; Chinnaiyan AM; Adami HO; Kantoff PW; Johansson JE
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1424-32. PubMed ID: 15941951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.